24 July 2019

AMRA Abstracts Presented at ISMRM Workshop in Singapore

AMRA Abstracts Presented at ISMRM Workshop in Singapore

SINGAPORE; July 24, 2019 – The International Society for Magnetic Resonance in Medicine (ISMRM) is a nonprofit association that promotes innovation, development, and application of magnetic resonance techniques in medicine and biology throughout the world. During July 21 – July 24 a workshop about MRI of Obesity & Metabolic Disorders took place in Singapore. Magnus Borga, PhD., Chief Technology Officer and Co-Founder, was invited to give a talk about Body Composition Analysis – Perspectives on Radiomics, Machine Learning and Big Data. AMRA also received two abstract acceptances for oral presentations which also were presented by Borga:

The background to these abstracts is that the association between NAFLD and sarcopenia has been reported, although results have been very inconclusive. However, sarcopenia is one of the most common complications related to the survival of patients with cirrhosis and commonly observed in end-stage liver disease. A large problem is that the latest consensus definition for sarcopenia (based on DXA estimated appendicular lean mass and handgrip strength) is lacking in terms of objectivity, reproducibility, and prognostic performance. This is even more problematic in the NAFLD/NASH (compared to the general population or many other diseases) space since the degree of ascites and amount of edema may interfere with the DXA assessment.

 “On the Definition of Sarcopenia in Non-Alcoholic Fatty Liver Disease (NAFLD) – Results from the Large UK Biobank Imaging Study”, Authors: Jennifer Linge, Magnus Borga, Olof Dahlqvist Leinhard

 “Adverse Muscle Composition within Non-Alcoholic Fatty Liver Disease (NAFLD) is Associated with Increased Comorbidity – Results from the Large UK Biobank Imaging Study”, Authors: Jennifer Linge, Magnus Borga, Olof Dahlqvist Leinhard

Visit our publications library to read more about AMRA’s ongoing research: www.amramedical.com/publications

AMRA is a ground-breaking international digital health company at the forefront of medical imaging and precision medicine. The company has developed a new global standard in body composition assessment, the ability to automatically produce multiple fat and muscle biomarkers with unrivaled precision and accuracy, as well as contextual disease insights – all from a single, 6-minute, whole-body MRI. AMRA was founded in 2010 as a spin-off of Linköping University, Sweden, with the aim to support transformative care and vital decision-making from clinical research to health and wellness.

Contact

Marie Börjesson
Senior Director, Brand & Marketing
marie.borjesson@amramedical.com

comment

Latest News

language

Meet Us Here